Sailong Pharmaceutical Group Co., Ltd. Profile Avatar - Palmy Investing

Sailong Pharmaceutical Group Co., Ltd.

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycli…

Biotechnology
CN, Zhuhai [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Sailong Pharmaceutical Group Co., Ltd. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

Sailong Pharmaceutical Group Co., Ltd. can't present spending by time.

End of 002898.SZ's Analysis
CIK: - CUSIP: - ISIN: CNE1000032S5 LEI: - UEI: -
Secondary Listings
002898.SZ has no secondary listings inside our databases.